Literature DB >> 26059704

Unclassifiable interstitial lung disease: A review.

Kate Skolnik1, Christopher J Ryerson2.   

Abstract

Accurate classification of interstitial lung disease (ILD) requires a multidisciplinary approach that incorporates input from an experienced respirologist, chest radiologist and lung pathologist. Despite a thorough multidisciplinary evaluation, up to 15% of ILD patients have unclassifiable ILD and cannot be given a specific diagnosis. The objectives of this review are to discuss the definition and features of unclassifiable ILD, identify the barriers to ILD classification and outline an approach to management of unclassifiable ILD. Several recent studies have described the characteristics of these patients; however, there are inconsistencies in the definition and terminology of unclassifiable ILD due to limited research in this population. Additional studies are required to determine the appropriate evaluation and management of patients with unclassifiable ILD.
© 2015 Asian Pacific Society of Respirology.

Entities:  

Keywords:  diffuse lung disease; idiopathic interstitial pneumonia; idiopathic pulmonary fibrosis; interstitial lung disease; unclassifiable

Mesh:

Year:  2015        PMID: 26059704     DOI: 10.1111/resp.12568

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  14 in total

1.  Risk factors for primary Sjögren syndrome-associated interstitial lung disease.

Authors:  Yong Wang; Ziliang Hou; Meihua Qiu; Qiao Ye
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

2.  Gremlin-1 for the Differential Diagnosis of Idiopathic Pulmonary Fibrosis Versus Other Interstitial Lung Diseases: A Clinical and Pathophysiological Analysis.

Authors:  Yoichiro Aoshima; Yasunori Enomoto; Shigeki Muto; Shiori Meguro; Hideya Kawasaki; Isao Kosugi; Tomoyuki Fujisawa; Noriyuki Enomoto; Naoki Inui; Yutaro Nakamura; Takafumi Suda; Toshihide Iwashita
Journal:  Lung       Date:  2021-03-26       Impact factor: 2.584

3.  Unclassifiable interstitial lung disease: an unresolved diagnostic dilemma.

Authors:  Stefanie C Leung; Andrew M Churg; Jonathon A Leipsic; Robert D Levy; Pearce G Wilcox; Christopher J Ryerson
Journal:  Respirol Case Rep       Date:  2015-06-09

4.  A Review of the Multidisciplinary Diagnosis of Interstitial Lung Diseases: A Retrospective Analysis in a Single UK Specialist Centre.

Authors:  Nazia Chaudhuri; Lisa Spencer; Melanie Greaves; Paul Bishop; Anshuman Chaturvedi; Colm Leonard
Journal:  J Clin Med       Date:  2016-07-27       Impact factor: 4.241

Review 5.  Current concepts and dilemmas in idiopathic interstitial pneumonias.

Authors:  Jay H Ryu; Teng Moua; Natalya Azadeh; Misbah Baqir; Eunhee S Yi
Journal:  F1000Res       Date:  2016-11-10

6.  Prognostic factors and outcomes in Japanese lung transplant candidates with interstitial lung disease.

Authors:  Kohei Ikezoe; Tomohiro Handa; Kiminobu Tanizawa; Toyofumi F Chen-Yoshikawa; Takeshi Kubo; Akihiro Aoyama; Hideki Motoyama; Kyoko Hijiya; Shinsaku Tokuda; Yoshinari Nakatsuka; Yuko Yamamoto; Ayako Oshima; Shin-Ichi Harashima; Sonoko Nagai; Toyohiro Hirai; Hiroshi Date; Kazuo Chin
Journal:  PLoS One       Date:  2017-08-11       Impact factor: 3.240

7.  Clinical spectrum and prognostic factors of possible UIP pattern on high-resolution CT in patients who underwent surgical lung biopsy.

Authors:  Yasuhiro Kondoh; Hiroyuki Taniguchi; Kensuke Kataoka; Taiki Furukawa; Ayumi Shintani; Tomoyuki Fujisawa; Takafumi Suda; Machiko Arita; Tomohisa Baba; Kazuya Ichikado; Yoshikazu Inoue; Kazuma Kishi; Tomoo Kishaba; Osamu Nishiyama; Takashi Ogura; Keisuke Tomii; Sakae Homma
Journal:  PLoS One       Date:  2018-03-28       Impact factor: 3.240

8.  Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trial.

Authors:  Toby M Maher; Tamera J Corte; Aryeh Fischer; Michael Kreuter; David J Lederer; Maria Molina-Molina; Judit Axmann; Klaus-Uwe Kirchgaessler; Vincent Cottin
Journal:  BMJ Open Respir Res       Date:  2018-09-04

9.  Design of a Study Assessing Disease Behaviour During the Peri-Diagnostic Period in Patients with Interstitial Lung Disease: The STARLINER Study.

Authors:  Marlies Wijsenbeek; Elisabeth Bendstrup; Claudia Valenzuela; Michael T Henry; Catharina Moor; Monica Bengus; Andras Perjesi; Frank Gilberg; Klaus-Uwe Kirchgaessler; Carlo Vancheri
Journal:  Adv Ther       Date:  2018-11-30       Impact factor: 3.845

Review 10.  Pulmonary Vasculitides: A Radiological Review Emphasizing Parenchymal HRCT Features.

Authors:  Stefano Palmucci; Corrado Inì; Salvatore Cosentino; Luigi Fanzone; Stefano Di Pietro; Alessia Di Mari; Federica Galioto; Francesco Tiralongo; Giovanna Vignigni; Stefano Toscano; Gianluca Sambataro; Carlo Vancheri; Giulio Distefano; Antonio Basile
Journal:  Diagnostics (Basel)       Date:  2021-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.